These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32466883)

  • 1. Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia.
    Trinder M; DeCastro ML; Azizi H; Cermakova L; Jackson LM; Frohlich J; Mancini GBJ; Francis GA; Brunham LR
    J Am Coll Cardiol; 2020 Jun; 75(21):2682-2693. PubMed ID: 32466883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia.
    Olmastroni E; Gazzotti M; Averna M; Arca M; Tarugi P; Calandra S; Bertolini S; Catapano AL; Casula M;
    J Am Heart Assoc; 2023 May; 12(10):e029223. PubMed ID: 37183858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Trinder M; Cermakova L; Ruel I; Baass A; Paquette M; Wang J; Kennedy BA; Hegele RA; Genest J; Brunham LR
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1683-1693. PubMed ID: 38779854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors].
    Real JT; Romero G; Priego MA; Chaves FJ; Ascaso JF; Carmena R
    An Med Interna; 1999 Feb; 16(2):69-72. PubMed ID: 10192997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia.
    Paquette M; Bernard S; Thanassoulis G; Baass A
    J Clin Lipidol; 2019; 13(4):627-633.e1. PubMed ID: 31103339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
    Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels.
    Pavanello C; Pirazzi C; Bjorkman K; Sandstedt J; Tarlarini C; Mosca L; Romeo S; Calabresi L; Mancina RM
    J Clin Lipidol; 2019; 13(5):778-787.e6. PubMed ID: 31371270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
    Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
    Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
    J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemia.
    Tromp TR; Ibrahim S; Nurmohamed NS; Peter J; Zuurbier L; Defesche JC; Reeskamp LF; Hovingh GK; Stroes ESG
    Atherosclerosis; 2023 Jan; 365():27-33. PubMed ID: 36473758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) in homozygous familial hypercholesterolemia.
    Kraft HG; Lingenhel A; Raal FJ; Hohenegger M; Utermann G
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):522-8. PubMed ID: 10669652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.
    Ellis KL; Pang J; Chieng D; Bell DA; Burnett JR; Schultz CJ; Hillis GS; Watts GF
    Clin Cardiol; 2018 Mar; 41(3):378-384. PubMed ID: 29480541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.
    Mbewu AD; Bhatnagar D; Durrington PN; Hunt L; Ishola M; Arrol S; Mackness M; Lockley P; Miller JP
    Arterioscler Thromb; 1991; 11(4):940-6. PubMed ID: 1829633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease.
    Real JT; Ascaso JF; Chaves FJ; Tenés S; Priego MA; Puig O; Armengod ME; Carmena R
    Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):41-4. PubMed ID: 10726108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia.
    Nenseter MS; Lindvig HW; Ueland T; Langslet G; Ose L; Holven KB; Retterstøl K
    Atherosclerosis; 2011 Jun; 216(2):426-32. PubMed ID: 21376325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
    Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
    J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.